Navigation Links
Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia
Date:6/30/2009

LONDON, June 30 /PRNewswire-FirstCall/ -- VEGA PROMOTIONAL SYSTEMS, INC. (Pink Sheets: VGPR) today announced it has chosen Chattanooga, TN based consulting firm, Tennessee Power Company, Inc. to assist the Company in building a biomass production facility in Georgia.

Vega recently announced its intention to build a biomass plant in Georgia to take advantage of the abundance of biomass materials in the State's Bioenergy Corridor. Georgia ranks third in the nation as a potential source of renewable energy. Approximately 50 million tons of Georgia's own timber ends up in the State's wood-products manufacturing plants every year and the industry returns nearly half of it in the form of primary mill wood debris.

Vega's Business Plan calls for manufacturing facilities to be constructed in various locations around the world. The Georgia plant would be the Company's first in the United States and would serve as a model facility for other plants in the U.S.

Biomass or biofuel is material derived from recently living organisms. This includes plants, animals and their bi-products. For example, manure, garden waste and crop residues are all sources of biomass. It is a renewable energy source based on the carbon cycle, unlike other natural resources such as petroleum, coal, and nuclear fuels. The use of biomass fuels can therefore contribute to waste management as well as fuel security and
'/>"/>

SOURCE Vega Promotional Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ORNL resilience plan to help Tennessee, Mississippi and South Carolina communities beat disaster
2. Noninvasive Medical Technologies Helps Make Young Tennessee Womans Wishes Come True
3. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
4. New Online Help Desk Offers Safe Lifting Assistance to Healthcare Facilities
5. Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
6. National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000
7. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
8. Bio Career Center Develops New Tool to Assist in Employer/Candidate Match
9. Quest PharmaTech Receives Support from National Research Councils Industrial Research Assistance Program (NRC-IRAP) to develop Ultrasound Technology for the Treatment of Cancer
10. CardiacAssist, Inc. Surpasses 1300 TandemHeart System Procedures
11. Vermillion Retains ThinkPanmure to Assist in the Evaluation of Potential Strategic Alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Calif. , May 23, 2013  Saddleback Memorial ... recently became the first hospital on the West ... technology. This new surgical option provides women with a ... Marc Winter , M.D., a ... and surgeon and medical director of minimally invasive surgery ...
(Date:5/23/2013)... May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... DCVax ® personalized immune therapies for solid tumor ... at this year,s American Society Of Clinical Oncology (ASCO) ... its leadership role in immune therapy.  (Logo: ... meeting is the pre-eminent conference focused on clinical treatment ...
(Date:5/23/2013)... , May 23, 2013 Pusan National ... a private biotherapeutics and contract research company focused ... for cancer, announced today a publication reporting the ... with the oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene ... was published in the May 15 th , ...
(Date:5/23/2013)... Louis, Missouri (PRWEB) May 23, 2013 ... and manufacture of complete thermal systems, recently introduced ... than 90 years of experience in designing and ... complete selection of products to serve diverse customer ... options is featured at the beginning of the ...
Breaking Biology Technology:Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Watlow Introduces Its New Industrial Heater Catalog 2
... IBD with Novel Mode of ActionMOUNTAIN VIEW, Calif., ... announced that data from the company,s PROTECT-1 (the ... Trial) Phase II/III clinical trial of Traficet-EN(TM) (CCX282-B) ... presented in an oral session at the upcoming ...
... Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) ... fiscal year ended February 28, 2009. Neptune reports ... three-month period ended February 28, 2009. Neptune and ... Neptune reports consolidated operating results for its nutraceutical ...
... saves time for reprint buyers by integrating the quote ... Calif., May 19 Reprints Desk, Inc., the content ... Reprints NRx for the Force.com AppExchange from salesforce.com ... the AppExchange is a procurement service that enables buyers ...
Cached Biology Technology:ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 3ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 5Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 2Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 3Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 4Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 5Reprints Desk Medical Reprint Service Now Available to Life Science Professionals on the Force.com AppExchange 2Reprints Desk Medical Reprint Service Now Available to Life Science Professionals on the Force.com AppExchange 3
(Date:5/21/2013)... known for a long time that some creatures evolve ... particularly for plants. But it may be that height ... University and the U. S. National Evolutionary Synthesis Center. ... May in the journal Nature Communications , Lanfear ... , Drawing from a database of global patterns in ...
(Date:5/21/2013)... considered in the management of natural resources, and ... help them recognize and respond to the relationships ... , Place-Based Conservation: Perspectives from the Social ... Northwest Research Station,s Linda Kruger, can help managers ... is published by Springer Verlag and is available ...
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Keeping stem cells strong 2
... This release is available in Spanish . , ... of Radiology and Physical Medicine of the University ... of Public Health (Escuela Andaluza de Salud Pblica), found ... of persistent organic compound (POCs), substances internationally classified as potentially ...
... finds that a chemical found in the body is capable ... in an animal model. The hormone is gastric inhibitory polypeptide ... is a peptide hormone that is secreted in response to ... insulin as part of the digestive process in response to ...
... PITTSBURGH Practice makes perfect or at least thats ... of multiplication tables, goal kicks and piano scales ... many, to be true. Thats why neuroscientists have ... of individual synapses, or connections between neurons, increased, repetitive ...
Cached Biology News:100 percent of people carry at least 1 type of pesticide 2100 percent of people carry at least 1 type of pesticide 3Human hormone blocker found to help prevent obesity and diabetes: study 2Human hormone blocker found to help prevent obesity and diabetes: study 3Novel mechanism for long-term learning identified by Carnegie Mellon researchers 2Novel mechanism for long-term learning identified by Carnegie Mellon researchers 3